INTRODUCTION
Schizophrenia is a complex and debilitating psychiatric illness with different subtypes. The neuropsychological basis of different syndromes and the specific symptoms of schizophrenia have b e e n i n v e s t i g a t e d . A w i d e l y a c c e p t e d classification system for distinguishing different subtypes of schizophrenia emphasizes the presence of negative or positive symptoms. Studies investigating neuropsychological performance in positive and negative clinical subtypes have revealed that performance in the positive symptom subtype was better than in the negative subtype on different neuropsychological measures (1) (2) (3) .
Another classification approach has been to classify schizophrenia as either paranoid or nonparanoid subtypes. It has been accepted that patients with paranoid schizophrenia demonstrate less impairment of neurocognitive functions compared to non-paranoid patients (4) (5) (6) . However, other studies have failed to demonstrate differences between subtypes in schizophrenia (7) (8) (9) .
In a review of studies from 1975 to 1995 examining the neurocognitive differences between paranoid and non-paranoid schizophrenia, the authors reviewed a total of 32 studies in which the two subtypes had been compared in terms of general intellectual functioning, executive functions, attention, memory, verbal abilities and visual-spatial and motor skills (10) . There was little empirical support for the hypothesis suggesting a higher IQ in the paranoid subtype. Similarly, no consistent findings were found for subtype differences in verbal abilities or visual-spatial skills. Limited support for neuropsychological differences favoring the paranoid group was found in executive functioning, attention, memory, and motor skills. The review offers only modest support for the notion of cognitive differences associated with paranoid and non-paranoid schizophrenia. The authors noted the factors limiting the reliability of studies such as methodological variability, and subject variables such as severity of illness, clinical state, medication effects, and sampling biases.
Studies attempting to clarify the patterns of neuropsychological differences in schizophrenia subtypes may lead to a better understanding of underlying pathophysiological processes. Here, we aimed to examine the cognitive differences b e t w e e n p a r a n o i d a n d n o n -p a r a n o i d schizophrenia subtypes. We hypothesized that paranoid schizophrenia patients would d e m o n s t r a t e h i g h e r n e u r o p s y c h o l o g i c a l performance compared to non-paranoid patients. Our hypothesis may reveal the importance of subtype-associated cognitive differences in schizophrenia, in association with the results of previous studies indicating the d i s t i n g u i s h i n g c l i n i c a l s y m p t o m s a n d neuroanatomical features.
METHODS

Subjects
Fifty-three inpatients meeting the DSM IV criteria for schizophrenia were included in this study. Patients were recruited from consecutive admissions to the psychiatric wards of Bakırköy Training and Research Hospital for Psychiatric and Neurological Diseases. Subjects were excluded from the study if they: (1) had a history of a neurological or medical disorder that would affect neuropsychological functioning, (i.e., seizures, head trauma with loss of consciousness, stroke, brain tumor, meningitis etc.) (2) had documented evidence of mental retardation, (3) had a history of alcohol or substance abuse/ dependence, or (4) had been treated with ECT within the previous 6 months.
Demographic data were obtained by interviews with patients and family members. A comprehensive neuropsychological test battery was administered to both groups.
Socio-demographic and clinical characteristics of the 53 patients are presented in Table 1 . Twentysix subjects (all male) were paranoid schizophrenic and 27 were non-paranoid schizophrenia patients (18 men, 9 women; 14 undifferentiated, 9 residual, and 4 disorganized subtypes). Mean age, duration of illness and number of previous hospitalizations in the paranoid patients were 38.0±9.1; 13.4±9.5; 6.0±3.8, respectively. These values in non-paranoid patients were 39.8±16.4; 15.3±12.9; 7.2±6.9, respectively. There were no significant differences between the two groups with respect to age, duration of illness or number of previous hospitalizations. The average duration of education was higher in the paranoid group when compared to the non-paranoid group. One possible explanation might be the earlier onset of illness in the non-paranoid patients; although, our results did not support any difference between the groups in duration of illness.
Group differences in demographic variables were examined with the Mann-Whitney U test for continuous data and the Chi-square test for categorical data. A multivariate analysis of variance (MANOVA) was performed with group as the between-group factor and cognitive domain (attention, learning and memory, executive function, language, and visuo-spatial perception) as the within-group factor in order to determine whether there was an interaction of group by cognitive functions. The average duration of education was higher in the paranoid group. Previous studies have clarified the effects of education on neurocognitive performance (11) (12) (13) . Group differences in neuropsychological performance were evaluated using a stratified ttest. Stratification was done into 3 educational groups (0-5 years, 6-8 years, 9 years or more) to adjust for the confounding effect of education. To investigate the possible effects of the duration of education on the group differences of cognitive performance, a two-factor factorial ANOVA was performed. Since there were 9 females in the nonparanoid group, the possible differences on cognitive tasks might be related to a gender effect. To c l a r i f y t h e e f f e c t o f g e n d e r o n neuropsychological performance in the nonparanoid group, we performed a MANOVA. Subjects provided informed consent in a matter approved by the Bakırköy Training and Research Hospital for Psychiatric and Neurological Diseases Institutional Review Board. This study was conducted in accordance with the Declaration of Helsinki.
Instruments
A comprehensive neurocognitive test battery was designed to evaluate a broad range of cognitive domains. These assessments focused on measures of attention, learning and memory, executive functions, language, and visuo-spatial perception. The battery included 11 tests that would assess these domains. These tests have been described extensively in prior researche (2, (14) (15) (16) (17) (18) (19) (20) (21) (22) 
Procedure
Following the clinical interview, the neurocognitive test battery was administered by study investigators trained in standardized assessment and experienced in working with psychotic patients. The test administrators were supervised by the principal investigator (SC). The test battery took about 2 hours to complete. Testing took place in a quiet room in sessions of about an hour each, at times when the patients were most cooperative and alert. Neuropsychological assessments were administered after patients had confirmed to be psychiatrically and medically stable for at least 2 weeks. At neuropsychological testing, 61.5% of paranoid and 77 % of nonparanoid patients were receiving haloperidol; 38.5% of paranoid and 23% of non-paranoid patients were receiving clozapine. There were no significant differences between groups according to the type of antipsychotic medication (chisquare=3.11, p=0.21) and according to the chlorpromazine (CPZ) equivalent dose (Table 1) .
Statistical Analysis
All statistical analyses were performed using the SPSS 10.0 for Windows (SPSS, Inc., Chicago, IL) and STATA data analysis and statistical software program. (StataCorp LP, Texas). An alpha level of 0.05 was considered to be statistically significant. Significance was evaluated by a two-tailed test. Group differences were examined by using MannWhitney U, Chi-square and the stratified t-test. Multivariate analysis of variance (MANOVA) and two-factor factorial ANOVA methods were used to determine main effects or interactions between the two groups in the test phase.
RESULTS
All comparisons between the paranoid and non-paranoid groups were made after adjustment for education by the stratified t-test. The results are presented in Tables 1, 1a and 2. The patients in the paranoid group performed significantly better than those in the non-paranoid group on measures of executive functions and learning/memory. On the Stroop test, paranoid patients made significantly fewer errors than non-paranoid patients. They did not differ in the number of corrections. On the SDLT, patients with paranoid schizophrenia learned the digits earlier than their non-paranoid counterparts. In the paranoid group, the average number of trials for exact learning was significantly fewer and the average total score was significantly higher than in the non-paranoid group. There were no significant differences between the two groups on other measures of executive functions and memory, or on measures of language and visuospatial perception functions. To evaluate whether there was a significant interaction of group (paranoid vs non-paranoid) by condition (5 domains of cognitive function), we performed a MANOVA. First, we determined the overall multivariate-F (Wilks' Lambda F) of the 5 domains of cognitive function. The Wilks' Lambda (WL), significance (p) and hypothesis degree of freedom (df) values for the 5 cognitive function domains were as follows: for attention, WL was 1.32, p was 0.28, df was 3.0; for learning and memory, these values were 2.56, 0.04, 6.0; for executive functions, 3.90, 0.01, 7.0; for language, 0.11, 0.89, 2.0, and for visuo-spatial functions, 1.70, 0.14, 3.0. Since the overall multivariate-F values were significant for learning and memory and executive functions, separate univariate analyses were performed to determine the group differences on these cognitive domains ( Table 2) . Our findings revealed significant group differences on the Stroop test and the SDLT results. Patients with paranoid schizophrenia performed better on the Stroop testand on the SDLT exact learning and total scores.
To evaluate whether these differences were attributable to group differences in educational level, a two-factor factorial ANOVA was performed. As a result, no differences were found between the groups in terms of educational level, except for the RAVLT. In the 0-5 year educational level, paranoid p<0.05, **p<0.01: significant between-group differences Group differences on neuropsychological performance were evaluated using the stratified t -test. To evaluate whether there was a significant interaction of group (paranoid vs non-paranoid) by condition (5 domains of cognitive function), we performed aMANOVA.
patients performed better on the RAVLT total score. (p<0.01, F=4.72) Although the performances of the paranoid patients were higher in this analysis, it seemed to be balanced when the overall group performance was analyzed by using the MANOVA. To evaluate the effects of gender on cognitive functions in the non-paranoid group, a MANOVA was performed. The results indicated that gender did not seem to have any effect on neurocognitive performance of the patients. There were no differences in performance between males a n d f e m a l e s o n t h e m e a s u r e s o f neuropsychological functioning in the nonparanoid patients. 
DISCUSSION
The main finding of this study was that patients with paranoid schizophrenia performed significantly better on executive and learning / memory functions compared to non-paranoid patients. There were no significant differences on other measures of neuropsychological functioning. Statistical analyses suggested that the observed group performance differences were not due to education or gender. When the education factor was statistically controlled, the non-paranoid group was still more severely impaired on executive and memory functions. These findings support previous studies which found that patients with paranoid schizophrenia performed significantly better than non-paranoid patients (35) (36) (37) (38) (39) (40) .
The first significant group difference was observed in the number of errors onthe Stroop Test. This would be consistent with reports of studies demonstrating that patients with paranoid schizophrenia performed better on the Stroop Task (37,41).
There were no significant differences between the two groups on other measures of executive function (Category Fluency Test, WCST and Raven Progressive Matrices Test). Our findings were similar to those of Kremen et al. , who found no differences between the two groups on WCST performance (9) . There are some studies indicating that paranoid patients performed better on the WCST compared to non-paranoid patients (5, 39) . However, Abburezze et al. found that paranoid patients made a higher number of perseverative errors on the WCST compared to non-paranoid Patients (42) . Taken together, as Zalewski et al. pointed out, the findings of the WCST studies do not strongly support subtype differences (10) .
The second significant group difference was observed on the Serial Digit Learning Test. In patients with paranoid schizophrenia, the number of trials for exact learning was lower and the total score was higher. Bornstein et al. have found that paranoid patients were less impaired than nonparanoids on both verbal and non-verbal components of the WMS-R (5). Kremen et al. have reported higher verbal memory skills in patients with a history of systematized delusions, as compared with patients without systematized delusions (9) . Contrary to these results, Kolb and Whishaw Hvw found no differences between paranoid and non-paranoid participants on visual or auditory memory (7) .
There were no group differences on other measures of memory such as the Rey Auditory Verbal Learning Test and the WMS-III Visual Reproduction Subtest. Our findings were consistent with Seltzer et al.'s findings that both paranoid and non-paranoid groups were equally impaired on the Rey AVLT (39). On measures of non-verbal memory, Bornstein et al. did not find any differences between the two groups (5). Similarly, Kremen et al. failed to demonstrate subtype differences on the WMS-R visual reproduction test (9) .
We found that patients with paranoid schizophrenia did not differ from non-paranoid patients on spatial distribution of attention, language, and visuo-spatial perception functions. Previous studies that have assessed attentional and verbal skills don't suggest subtype differences. As Zalewski et al. indicated, there was little evidence to suggest that subgroups differed on measures of visuo-spatial ability (10). Kremen et al. found no differences between groups on the CPT and the Cancellation test (9) . Our findings are consistent with previous reports (9, 10) .
The Stroop Test has been defined as a measure of executive function (19) . It has also been reported to be a means of assessing attentional matrix, specifically selective attention (17) . Studies of neurocognitive functioning in schizophrenia have considered the Stroop task as a measure of selective attention (43) (44) (45) (46) . It has been hypothesized that the Stroop Test was associated with the focus-execute component of attention (47) . In a study of construct validity of various verbal and visual memory tests, Larrabee and Curtiss found that the Serial Digit Learning Test was more closely associated with attention/ information processing than with general memory (48) . In our study, the main group differences were observed on the Stroop Test and the Serial Digit Learning Test. If we consider these two tests as measures of selective attention, we might suggest that patients with paranoid schizophrenia demonstrated higher performance on selective attention tasks compared to nonparanoid patients.
The current study has several limitations. First, our sample size was relatively small. This probably decreased the power of the statistical analysis. Second, we couldn't measure the illness severity, general IQ, and clinical status in our patient groups. Another issue was the chronicity of illness. Even though there were no significant differences on duration of disease between the two groups in our sample, we cannot estimate the impact of institutionalization on cognitive abilities especially in the non-paranoid group. There were also trends toward gender differences on measures of executive functions in the non-paranoid group. Although these differences were not significant, could potentially confound the results. We could have also considered the possible effects of medications on our findings. Although the subgroups did not differ statistically according to the type of antipsychotic medication, we cannot exactly estimate the effects of neuroleptic and anticholinergic drugs on neurocognitive performance. Our study sample did not include healthy subjects as a control group. We compared the cognitive functions between paranoid and non-paranoid schizophrenia in a cross-sectional study design, therefore we were not able to follow up the prognosis of these functions. Because of these limitations, our results are suggestive rather than conclusive.
Schizophrenia should not be regarded as a homogenous disorder with respect to cognitive skills. There may be significant differences among diagnostic subgroups in the degree of neuropsychological functioning. Cognitive differences might reflect the underlying neurocognitive processes in schizophrenia subtypes. These differences may also be related with lower illness severity and better prognosis in paranoid subgroups.
In summary, we have found evidence of differential performance on selective attention/ executive function and learning/ memory measures in patients with paranoid and nonparanoid schizophrenia. These differences were not attributable to either educational level or gender. Patients with paranoid schizophrenia seem to focus more selectively and be less susceptible to the confounding effects of Stroop interference. They also tend to record numerical information more quickly and seem to learn numerical information better than verbal information. These results might suggest that paranoid patients might have a better cognitive ability to focus on, to record, and recall information selectively.
A major obstacle to the identification of the neurobiological correlates of schizophrenia is the substantial clinical heterogeneity present in this disorder. Dividing schizophrenia into "paranoid" and "non-paranoid" subtypes may reduce heterogeneity and facilitate identification of neurobiological markers of disease.
Neuroimaging studies in schizophrenia have revealed distinguishing findings amongst subtypes and predominant symptoms. Schizophrenic p a t i e n t s s h o w e d a d e c r e a s e i n t h e N-acetylaspartate/creatine (NAA/Cr) ratio in the left medial temporal lobe, and patients with the disorganized subtype of the illness showed significantly lower NAA/Cr and choline/creatine (Cho/Cr) ratios than those with paranoid schizophrenia. These findings suggest that patients with the disorganized and undifferentiated subtypes had greater impairments in neuronal integrity or function in the left medial temporal lobe than patients with other subtypes of schizophrenia (49) . P300 amplitude when viewing a photograph of a smiling baby was the smallest registered of three photographs for healthy subjects and paranoid type patients with successively greater amplitudes for neutrality and sadness. These results suggest that the P300 amplitude was influenced by viewing emotionally moving facial expressions and that the effect is different for different subtypes of schizophrenia (50) .
Schneiderian symptoms may be associated with morphological abnormalities in the limbicparalimbic regions such as the cingulate gyrus and parahippocampal gyrus (51) . The findings of a voxel-based morphometry study revealed volume loss in the right superior temporal gyrus, right middle temporal gyrus, and right anterior cingulate gyrus among antipsychotic-naive first-episode schizophrenia patients. In addition, the functional networks involving the right superior temporal gyrus and middle temporal gyrus were associated with positive symptom severity (52) . The findings of an MRI study suggest that temporal and parietal cortical abnormalities might be associated mainly with positive symptoms, while medial temporal and ventricular system abnormalities may be associated with both positive and negative symptoms (53) . Regional abnormalities in brain structure may offer an account for some impaired cognitive domains in patients with schizophrenia (54, 55) . Schizophrenic patients with high negative symptoms had generalized prefrontal white matter reductions that were most severe in the orbitofrontal subregion. The convergence of findings for schizophrenic patients regarding the p r e f r o n t a l r e g i o n , n e g a t i v e s y m p t o m s, psychomotor speed and cognitive flexibility suggests that schizophrenic negative symptoms might involve disruption of frontal-subcortical connections (56, 57) .
The results of our study suggest that, current diagnostic classifications might not be the most useful factors for studies of the cognitive correlates of schizophrenia.
The DSM-5, as noted in its own appendix, has made several amendments in its section on Schizophrenia Spectrum and Other Psychotic Disorders. These amendments include the elimination of the older Kraepelinean sub-types such as paranoid or disorganized, and the de-emphasis of bizarre positive symptoms, which previously were on their own sufficient for a diagnosis, but now must be accompanied by at least one other core symptom. It seems possible that the DSM-5 has been pointing to future manuals in which there will be increasing efforts to make the pieces of this disorder easier to recognize, but with less concern for core psychopathological processes such as those proposed by Bleuler, which allow us to make sense of how schizophrenia spectrum disorders represent as a unique set of disorders. With regard to the diagnostic criteria for schizophrenia, changes include the elimination of the special attribution of bizarre delusions and first-rank auditory hallucinations according to Schneider's criteria. The traditional sub-typing of schizophrenia into paranoid, disorganized (hebephrenic), catatonic, undifferentiated, and residual forms is also now being discarded altogether, based on the view that sub-types were diagnostically unstable, unreliable, and invalid. In fact, auditory hallucinations in the form of commenting voices and other first-rank symptoms are 'core' to all early recognition manuals, including the most widely used Structured Interview for Psychotic Symptoms (SIPS) or the Comprehensive Assessment of At-Risk Mental States (CAARMS). It was the explicit goal of the early protagonists in psychiatry such as Kahlbaum and Kraepelin to describe clinical 'entities' based on symptomatology (which at the time included not just the subjective aspect of symptomatology, but also non-verbal and paraverbal abnormalities in expression), course and outcome. Many clinicians probably share the view that an insidious early onset of schizophrenia, rapid development of negative symptoms, poor insight, and behavioral abnormalities (that is, hebephrenia) were generally associated with a poorer prognosis respecting recovery, social functioning, and quality of life, compared with patients with acute paranoid schizophrenia (58) .
Future studies should focus on selective attention, learning/memory and information processing functions in schizophrenia by using more specific measures. These studies might include larger sample sizes with different control groups. Symptom severity and illness chronicity should be evaluated. Possible confounding effects of education, gender, and medication should be considered. These will be crucial in the d e v e l o p m e n t o f a n e u r o p s y c h o l o g i c a l understanding of the cognitive impairments observed in schizophrenia subtypes.
